A modular cell-type focused inflammatory process network model for non-diseased pulmonary tissue

Bioinformatics and Biology Insights

Volumn 7, Issue , 2013, Pages 167-192

  Westra, Jurjen W ^a   Schlage, Walter K ^b   Hengstermann, Arnd ^b   Gebel, Stephan ^b   Mathis, Carole ^c   Thomson, Ty ^a   Wong, Ben ^a   Hoang, Vy ^a   Veljkovic, Emilija ^c   Peck, Michael ^c   Lichtner, Rosemarie B ^b   Weisensee, Dirk ^b   Talikka, Marja ^c   Deehan, Renee ^a   Hoeng, Julia ^c   Peitsch, Manuel C ^c  

^a Selventa   (United States)

^b Philip Morris Research Laboratories GmbH   (Germany)

^c PHILIP MORRIS PRODUCTS S A   (Switzerland)

Author keywords

Biological expression language (BEL); Cigarette smoke; Gene expression; Inflammation; Network model; Reverse causal reasoning (RCR)

Indexed keywords

CIGARETTE SMOKE;

ARTICLE; AUTOANALYSIS; BRONCHUS MUCUS; CAUSAL MODELING; COMPUTER ANALYSIS; DATA ANALYSIS; ENVIRONMENTAL EXPOSURE; HUMAN; INFLAMMATION; INFLAMMATORY PROCESS NETWORK MODEL; KNOWLEDGE BASE; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; MUCUS SECRETION; NONHUMAN; PERMEABILITY BARRIER; PNEUMONIA; REVERSE CAUSAL REASONING; SMOKING; TEMPORAL ANALYSIS; TRANSCRIPTOMICS;

EID: 84879307956     PISSN: 11779322     EISSN: None     Source Type: Journal    
DOI: 10.4137/BBI.S11509     Document Type: Article

References (89)

1. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428-35.
2. Smith CJ, Hansch C. The relative toxicity of compounds in mainstream cigarette smoke condensate. Food Chem Toxicol. 2000;38(7):637-46.
3. Smith CJ, Perfetti TA, Morton MJ, etal. The relative toxicity of substituted phenols reported in cigarette mainstream smoke. Toxicol Sci. 2002;69: 265-78.
4. Cantin AM. Cellular response to cigarette smoke and oxidants: adapting to survive. Proc Am Thorac Soc. 2010;7:368-75.
5. Barnes, PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8:183-92.
6. Tuder RM, Yoshida T, Fijalkowka I, Biswai S, Petrache I. Role of lung maintenance program in the heterogeneity of lung destruction in emphysema. Proc Am Thorac Soc. 3, 673-9.
7. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2:372-7.
8. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J. 2008;31: 1334-56.
9. Taylor JD. COPD and the response of the lung to tobacco smoke exposure. Pulm Pharmacol Ther. 2010;23:376-83.
10. Tetley TD. Inflammatory cells and chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy. 2005;4:607-18.
11. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-74.
12. Yang IA, Relan V, Wright CM, etal. Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opin Ther Targets. 2011;15:439-56.
13. Stampfli MR, Anderson GP. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol. 2009;9: 377-84.
14. Thorley AJ, Tetley TD. Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2007;2: 409-28.
15. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22:672-88.
16. Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev. 2007;87:1047-82.
17. Morbini P, Villa C, Campo I, Zorzetto M, Inghilleri S, Luisetti M. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod Pathol. 2006;19:1437-45.
18. Reynolds PR, Kasteler SD, Schmitt RE, Hoidal JR. RAGE Signals through Ras during Tobacco Smoke-Induced Pulmonary Inflammation. Am J Respir Cell Mol Biol. 2011;45:411-8.
19. Chen GY, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10:826-37.
20. Hodge S, Hodge G, Ahem J, Jersmann H, Holmes M, Reynolds PN. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2007;37:748-55.
21. King TE Jr, Savici D, Campbell PA. Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers. J Infect Dis. 1988;158:1309-16.
22. Mucida D, Cheroutre H. The many face-lifts of CD4 T helper cells. Adv Immunol. 2010;107:139-52.
23. Curtis JL, Freeman CM, Hogg JC. The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc. 2007;4:512-21.
24. Woodruff PG, Koth LL, Yang YH, etal. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med. 2005;172:1383-92.
25. Rogers DF. Physiology of airway mucus secretion and pathophysiology of hypersecretion. Respir Care. 2007;52:1134-46; discussion 1146-9.
26. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev. 2004;56:515-48.
27. Barnes PJ. The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest. 2008;118:3546-56.
28. Murugan V, Peck MJ. Signal transduction pathways linking the activation of alveolar macrophages with the recruitment of neutrophils to lungs in chronic obstructive pulmonary disease. Exp Lung Res. 2009;35:439-85.
29. de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol. 2000;190:619-26.
30. Russell RE, Thorley A, Culpitt SV, etal. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol. 2002;283:L867-73.
31. Mio T, Romberger DJ, Thompson AB, Robbins RA, Heires A, Rennart SI. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med. 1997;155:1770-6.
32. Parsanejad R, Fields WR, Morgan WT, Bombick BR, Doolittle DJ. The time course of expression of genes involved in specific pathways in normal human bronchial epithelial cells following exposure to cigarette smoke. Exp Lung Res. 2008;34:513-30.
33. Stevenson CS, Docx C, Webster R, etal. Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation. Am J Physiol Lung Cell Mol Physiol. 2007;293: L1183-93.
34. Steiling K, Kadar AY, Bergerat A, etal. Comparison of proteomic and transcriptomic profiles in the bronchial airway epithelium of current and never smokers. PLoS One. 2009;4:e5043.
35. Veljkovic E, Jiricny J, Menigatti M, Rehrauer H, Han W. Chronic exposure to cigarette smoke condensate in vitro induces epithelial to mesenchymal transition-like changes in human bronchial epithelial cells, BEAS-2B. Toxicol In Vitro. 2011;25:446-53.
36. Heguy A, O'Connor TP, Luettich K, etal. Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J Mol Med. 2006;84:318-28.
37. Adair-Kirk TL, Atkinson JJ, Griffin GL, etal. Distal airways in mice exposed to cigarette smoke: Nrf2-regulated genes are increased in Clara cells. Am J Respir Cell Mol Biol. 2006;39:400-11.
38. Westra, JW, Schiage WK, Frushour BP, etal. Construction of a computable cell proliferation network focused on non-diseased lung cells. BMC Syst Biol. 2011;5:105.
39. Schlage WK, Westra JW, Gebel S, etal. A computable cellular stress network model for non-diseased pulmonary and cardiovascular tissue. BMC Syst Biol. 2011;5:168.
40. Valenca, SS, Silva Benzerra F, Lopes AA, etal. Oxidative stress in mouse plasma and lungs induced by cigarette smoke and lipopolysaccharide. Environ Res. 2008;108:199-204.
41. Mortaz E, Henricks PA, Kraneveid AD, Givi ME, Garssen J, Folkerts G. Cigarette smoke induces the release of CXCL-8 from human bronchial epithelial cells via TLRs and induction of the inflammasome. Biochim Biophys Acta. 2011;1812:1104-10.
42. Doz E, Noulin N, Boichot E, etal. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88signaling dependent. J Immunol. 2008;180:1169-78.
43. Gebel S, Diehl S, Pype J, etal. The transcriptome of Nrf2-/-mice provides evidence for impaired cell cycle progression in the development of cigarette smoke-induced emphysematous changes. Toxicol Sci. 2010;115: 238-52.
44. Doyle I, Ratcliffe M, Walding A, etal. Differential gene expression analysis in human monocyte-derived macrophages: impact of cigarette smoke on host defence. Mol Immunol. 2010;47:1058-65.
45. Jeffery PK, Ayers M, Rogers D. The mechanisms and control of bronchial mucous cell hyperplasia. Adv Exp Med Biol. 1982;144:399-409.
46. Borchers MT, Wert SE, Leikauf GD. Acrolein-induced MUC5ac expression in rat airways. Am J Physiol. 1998;274:L573-81.
47. Choi WI, Syrkina O, Kwon KY, Quinn DA, Hales CA. JNK activation is responsible for mucus overproduction in smoke inhalation injury. Respir Res. 2010;11:172.
48. Richardson PS, Peatfield AC. The control of airway mucus secretion. Eur J Respir Dis Suppl. 1987;153:43-51.
49. Shaykhiev R, Krause A, Salit J, etal. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol. 2009;183:2867-83.
50. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677-86.
51. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci. 2008;13:453-61.
52. Neve BP, Fruchart JC, Staels B. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. Biochem Pharmacol. 2000; 60:1245-50.
53. Ikezumi Y, etal. Contrasting effects of steroids and mizoribine on macrophage activation and glomerular lesions in rat thy-1mesangial proliferative glomerulonephritis. Am J Nephrol. 2010;31:273-82.
54. Bellon T, Martinez V, Lucendo B, etal. Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis. Nephrol Dial Transplant. 2011;26:2995-3005.
55. Spira A, Beane J, Shah V, etal. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci U S A. 2004;101: 10143-8.
56. Finigan JH, Faress JA, Wilkinson E, etal. Neuregulin-1-human epidermal receptor-2signaling is a central regulator of pulmonary epithelial permeability and acute lung injury. J Biol Chem. 2011;286:10660-70.
57. Basuroy S, Sheth P, Kuppuswamy D, etal. Expression of kinase-inactive c-Src delays oxidative stress-induced disassembly and accelerates calcium-mediated reassembly of tight junctions in the Caco-2 cell monolayer. J Biol Chem. 2003;278:11916-24.
58. Shao MX, Nadel JA. Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzyme. J Immunol. 2005;175:4009-16.
59. Gensch E, Gallup M, Sucher A, etal. Tobacco smoke control of mucin production in lung cells requires oxygen radicals AP-1 and JNK. J Biol Chem. 2004;279:39085-93.
60. Fujisawa T, Ide K, Holzman MJ, etal. Involvement of the p38 MAPK pathway in IL-13-induced mucous cell metaplasia in mouse tracheal epithelial cells. Respirology. 2008;13:191-202.
61. Rencken RK, Jansen AA, Bornman MS, Reif S. Trauma of the ureter. S Afr J Surg. 1991;29:154-7.
62. Yu H, Li Q, Kolosov VP, Pereiman JM, Zhou X. Interleukin-13 induces mucin 5AC production involving STAT6/SPDEF in human airway epithelial cells. Cell Commun Adhes. 2010;17:83-92.
63. Chen G, Korfhagen TR, Xu Y, etal. SPDEF is required for mouse pulmonary goblet cell differentiation and regulates a network of genes associated with mucus production. J Clin Invest. 2009;119:2914-24.
64. Maunders H, Patwardhan S, Phillips J, Clack A, Richter A. Human bronchial epithelial cell transcriptome: gene expression changes following acute exposure to whole cigarette smoke in vitro. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1248-56.
65. Samet JM, Cheng PW. The role of airway mucus in pulmonary toxicology. Environ Health Perspect. 1994;102(Suppl 2):89-103.
66. Mebratu YA, Schwaim K, Smith KR, Schuyler M, Tesfaigzi Y. Cigarette smoke suppresses Bik to cause epithelial cell hyperplasia and mucous cell metaplasia. Am J Respir Crit Care Med. 2011;183:1531-8.
67. Almolki A, Guenogou A, Golda S, etal. Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans. Am J Pathol. 2008;173:981-92.
68. Shaykhiev R, Otaki F, Bonsu P, etal. Cigarette smoking reprograms apical junctional complex molecular architecture in the human airway epithelium in vivo. Cell Mol Life Sci. 2011;68:877-92.
69. Dwyer TM. Cigarette smoke-induced airway inflammation as sampled by the expired breath condensate. Am J Med Sci. 2003;326:174-8.
70. Takeyama K, etal. Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol. 2001;280:L165-72.
71. Shao MX, Nakanaga T, Nadel JA. Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alpha-converting enzyme in human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol. 2004;287:L420-7.
72. Borchers MT, Carty MP, Leikauf GD. Regulation of human airway mucins by acrolein and inflammatory mediators. Am J Physiol. 1999;276: L549-55.
73. Borchers MT, Wesselkamper S, Wert SE, Shapiro SD, Leikauf GD. Monocyte inflammation augments acrolein-induced Muc5ac expression in mouse lung. Am J Physiol. 1999;277:L489-97.
74. Deshmukh HS, Case LM, Wesselkamper SC, etal. Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation. Am J Respir Crit Care Med. 2005;171:305-14.
75. Lloyd CM, Hessel EM. Functions of T cells in asthma: more than just T(H)2 cells. Nat Rev Immunol. 2010;10:838-48.
76. Sahlander K, Larsson K, Palmberg L. Altered innate immune response in farmers and smokers. Innate Immun. 2010;16:27-38.
77. Lamb D, Lumsden A. Intra-epithelial mast cells in human airway epithelium: evidence for smoking-induced changes in their frequency. Thorax. 1982;37:334-42.
78. Battaglia S, Mauad T, van Schadewijk AM, etal. Differential distribution of inflammatory cells in large and small airways in smokers. J Clin Pathol. 2007;60:907-11.
79. Cohn L. Mucus in chronic airway diseases: sorting out the sticky details. J Clin Invest. 2006;116:306-8.
80. Haswell LE, Hewitt K, Thorne D, Richter A, Gaca MD. Cigarette smoke total particulate matter increases mucous secreting cell numbers in vitro: a potential model of goblet cell hyperplasia. Toxicol In Vitro. 2010;24: 981-7.
81. Calvano SE, Xiao W, Richards DR, etal. A network-based analysis of systemic inflammation in humans. Nature. 2005;437:1032-7.
82. Patil S, Pincas H, Seto J, Nudelman G, Nudelman I, Sealfon SC. Signaling network of dendritic cells in response to pathogens: a community-input supported knowledgebase. BMC Syst Biol. 2010;4:137.
83. Seok J, Xiao W, Moldawer LL, Davis RW, Covert MW. A dynamic network of transcription in LPS-treated human subjects. BMC Syst Biol. 2009;3:78.
84. Oda K, Kitano H. A comprehensive map of the toll-like receptor signaling network. Mol Syst Biol. 2006;2:2006 0015.
85. Antila L. Insurance cases of cerebral concussion. Duodecim. 1957;73: 320-8.
86. Irizarry RA, Hobbs B, Collin F, etal. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249-64.
87. Rauramo L, Lagerspetz K, Engblom P, Punnonen R. The effect of castration and peroral estrogen therapy on some psychological functions. Front Horm Res. 1975;3:94-104.
88. Carpentier J, Luyckx AS, Lefebvre PJ. Influence of metformin on arginine-induced glucagon secretion in human diabetes. Diabete Metab. 1975;1: 23-8.
89. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3.